Greg Rubin, Annette Berendsen, S Michael Crawford, Rachel Dommett, Craig Earle, Jon Emery, Tom Fahey, Luigi Grassi, Eva Grunfeld, Sumit Gupta, Willie Hamilton, Sara Hiom, David Hunter, Georgios Lyratzopoulos, Una Macleod, Robert Mason, Geoffrey Mitchell, Richard D Neal, Michael Peake, Martin Roland, Bohumil Seifert, Jeff Sisler, Jonathan Sussman, Stephen Taplin, Peter Vedsted, Teja Voruganti, Fiona Walter, Jane Wardle, Eila Watson, David Weller, Richard Wender, Jeremy Whelan, James Whitlock, Clare Wilkinson, Niek de Wit, Camilla Zimmermann
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal...
September 2015: Lancet Oncology